Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Margaritopoulos, K. Antoniou, K. Karagiannis, E. Vassalou, I. Lasithiotaki, R. Lymbouridou, N. Siafakas (Heraklion Crete, Greece). Investigation of angiogenetic axis angiopoietins 1 and 2/Tie-2 in fibrotic lung diseases. Eur Respir J 2010; 36: Suppl. 54, 4169

Member's Comments

No comment yet.

Related content which might interest you: The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001 Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Neutrophil vascular endothelial growth factor (VEGF) as a driving force for angiogenesis in bronchiectasis? Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Targeting TNF-alpha in inflammatory lung diseases Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 CX3CR1–fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases Source: Eur Respir J, 55 (2) 1900460; 10.1183/13993003.00460-2019 Year: 2020 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 FGFs in lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 Haemophilus influenzae (NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010